ArticleCell death & disease2026

Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway.

Yang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.